These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 15047172

  • 1. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):223-9. PubMed ID: 15047172
    [Abstract] [Full Text] [Related]

  • 2. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K, Tangirala RK, Chun S, Usher D, Puré E, Rader DJ.
    Mol Ther; 2000 Feb 23; 1(2):189-94. PubMed ID: 10933930
    [Abstract] [Full Text] [Related]

  • 3. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P, Pospisilova N, Jamborova G, Pospechova K, Solichova D, Andrys C, Zdansky P, Micuda S, Semecky V.
    Life Sci; 2008 Mar 26; 82(13-14):708-17. PubMed ID: 18289605
    [Abstract] [Full Text] [Related]

  • 4. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T, Shimano H, Chen Z, Ishibashi S, Yamada N.
    Horm Metab Res; 2001 Aug 26; 33(8):472-9. PubMed ID: 11544561
    [Abstract] [Full Text] [Related]

  • 5. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T, Aragane K, Fujinami K, Kojima K, Ishibashi S, Yamada N, Kusunoki J.
    Br J Pharmacol; 2001 Aug 26; 133(7):1005-12. PubMed ID: 11487509
    [Abstract] [Full Text] [Related]

  • 6. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 7. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C, Pedersen TX, Gordts PL, Roebroek AJ, Dahlbäck B, Nielsen LB.
    Circ Res; 2010 May 28; 106(10):1624-34. PubMed ID: 20360257
    [Abstract] [Full Text] [Related]

  • 8. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
    Babaev VR, Ding L, Reese J, Morrow JD, Breyer MD, Dey SK, Fazio S, Linton MF.
    Circulation; 2006 Jan 03; 113(1):108-17. PubMed ID: 16380543
    [Abstract] [Full Text] [Related]

  • 9. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 03; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 10. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    Lloyd DJ, McCormick J, Helmering J, Kim KW, Wang M, Fordstrom P, Kaufman SA, Lindberg RA, Véniant MM.
    Am J Physiol Endocrinol Metab; 2008 Mar 03; 294(3):E496-505. PubMed ID: 18160459
    [Abstract] [Full Text] [Related]

  • 11. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC.
    Arterioscler Thromb Vasc Biol; 2005 Apr 03; 25(4):785-90. PubMed ID: 15692094
    [Abstract] [Full Text] [Related]

  • 12. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW.
    Arterioscler Thromb Vasc Biol; 2010 Apr 03; 30(4):742-8. PubMed ID: 20110573
    [Abstract] [Full Text] [Related]

  • 13. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T, Li Y, Shih DM, Wang X, Laubach VE, Matsumoto AH, Helm GA, Lusis AJ, Shi W.
    Life Sci; 2006 Jul 04; 79(6):525-31. PubMed ID: 16516241
    [Abstract] [Full Text] [Related]

  • 14. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J, Csanyi G, Gajda M, Mateuszuk L, Lomnicka M, Korbut R, Chlopicki S.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):129-35. PubMed ID: 17174298
    [Abstract] [Full Text] [Related]

  • 15. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA, Papachristou DJ, Kotsikogianni I, Giopanou I, Kypreos KE.
    FEBS J; 2011 Sep 05; 278(17):3119-29. PubMed ID: 21740524
    [Abstract] [Full Text] [Related]

  • 16. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y, Su B, Jacobs RL, Kennedy B, Francis GA, Waddington E, Brosnan JT, Vance JE, Vance DE.
    Arterioscler Thromb Vasc Biol; 2009 Sep 05; 29(9):1349-55. PubMed ID: 19520976
    [Abstract] [Full Text] [Related]

  • 17. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec 05; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 18. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR, Hasty AH.
    Am J Physiol Endocrinol Metab; 2007 Aug 05; 293(2):E492-9. PubMed ID: 17566116
    [Abstract] [Full Text] [Related]

  • 19. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 20. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S, Combadière C, Esposito B, Lecureuil C, Ait-Oufella H, Merval R, Ardouin P, Tedgui A, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2006 Aug 01; 26(8):1858-63. PubMed ID: 16763157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.